Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?

Date
2016
Author
Yarman, Sema
Selcukbiricik, Ozlem Soyluk
Tanrikulu, Seher
Dogansen, Sema Ciftci
Metadata
Show full item record
Abstract
Purpose The aim of the study was to assess the effect of dopamine agonist (DA) withdrawal, the current recurrence rate of hyperprolactinemia, and possible factors that predict recurrence in patients with prolactinoma.
URI
http://hdl.handle.net/20.500.12627/11688
https://doi.org/10.1007/s11102-016-0708-3
Collections